Search
AI x Bio Summit: The CEO of Alto Neuroscience, which is working on precision medicine for neuroscience, talks about how the company is using AI and machine learning in its development programs
Amit Etkin says Alto Neuro is trying to use machine learning to understand signals from the complexity of the brain, and the company is...
Jul 22
Alto Neuroscience's CEO on today's $128.6 million NYSE IPO
Amit Etkin describes Alto's approach to tyring to bring precision medicine to psychiatry.
Feb 2, 2024
Alto Neuroscience's CEO on why MDD data at #ACNP2023 may validate its precision medicine approach
Amit Etkin says that psychiatric conditions have been treated too broadly in the past.
Dec 4, 2023
.png){kind=logo}
